73 related articles for article (PubMed ID: 25702411)
1. Synthesis and activity of a cyclo-heptapeptide containing Lys-Gly-Asp-sequence as a novel anti-platelet agent.
Jing J
Bioorg Khim; 2013; 39(5):547-51. PubMed ID: 25702411
[TBL] [Abstract][Full Text] [Related]
2. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet aggregation of a mutant proinsulin chimera engineered by introduction of a native Lys-Gly-Asp-containing sequence.
Jing J; Lu S
Biotechnol Lett; 2005 Sep; 27(17):1259-65. PubMed ID: 16215822
[TBL] [Abstract][Full Text] [Related]
4. Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa.
Scarborough RM; Naughton MA; Teng W; Rose JW; Phillips DR; Nannizzi L; Arfsten A; Campbell AM; Charo IF
J Biol Chem; 1993 Jan; 268(2):1066-73. PubMed ID: 8419315
[TBL] [Abstract][Full Text] [Related]
5. A potent anti-thrombosis peptide (vasotab TY) from horsefly salivary glands.
Zhang Z; Gao L; Shen C; Rong M; Yan X; Lai R
Int J Biochem Cell Biol; 2014 Sep; 54():83-8. PubMed ID: 25025626
[TBL] [Abstract][Full Text] [Related]
6. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
Flouret G; Chaloin O; Borovickova L; Slaninová J
J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
[TBL] [Abstract][Full Text] [Related]
7. The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of action.
Yang G; Zhu H; Zhao M; Wu J; Wang Y; Wang Y; Zheng M; Chen M; Liu J; Peng S
Mol Biosyst; 2012 Oct; 8(10):2672-9. PubMed ID: 22801714
[TBL] [Abstract][Full Text] [Related]
8. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
9. Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa.
Fisher MJ; Gunn B; Harms CS; Kline AD; Mullaney JT; Nunes A; Scarborough RM; Arfsten AE; Skelton MA; Um SL; Utterback BG; Jakubowski JA
J Med Chem; 1997 Jun; 40(13):2085-101. PubMed ID: 9207949
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of a cyclic RGD peptide that inhibits platelet aggregation.
Jois SD; Tambunan US; Chakrabarti S; Siahaan TJ
J Biomol Struct Dyn; 1996 Aug; 14(1):1-11. PubMed ID: 8877556
[TBL] [Abstract][Full Text] [Related]
11. Design of a new class of orally active fibrinogen receptor antagonists.
Klein SI; Molino BF; Czekaj M; Gardner CJ; Chu V; Brown K; Sabatino RD; Bostwick JS; Kasiewski C; Bentley R; Windisch V; Perrone M; Dunwiddie CT; Leadley RJ
J Med Chem; 1998 Jul; 41(14):2492-502. PubMed ID: 9651154
[TBL] [Abstract][Full Text] [Related]
12. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997
[TBL] [Abstract][Full Text] [Related]
13. Amino acids and peptides. XXVII. Solid phase synthesis of fibrinogen-related peptides with disulfide bond formed on solid support.
Kakiuchi M; Izuno Y; Maeda M; Ueda K; Fujiwara K; Kunitada S; Kawasaki K
Chem Pharm Bull (Tokyo); 1996 May; 44(5):1107-10. PubMed ID: 8689720
[TBL] [Abstract][Full Text] [Related]
14. An endothelin-3-related synthetic biotinylated pentapeptide as a novel inhibitor of platelet-activating factor.
Sato A; Suzuki T; Oikawa K; Ohta R; Ebina K
Eur J Pharmacol; 2013 Aug; 714(1-3):142-7. PubMed ID: 23792041
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library.
O'Neil KT; Hoess RH; Jackson SA; Ramachandran NS; Mousa SA; DeGrado WF
Proteins; 1992 Dec; 14(4):509-15. PubMed ID: 1438188
[TBL] [Abstract][Full Text] [Related]
16. A branched fluorescent peptide probe for imaging of activated platelets.
Tung CH; Quinti L; Jaffer FA; Weissleder R
Mol Pharm; 2005; 2(1):92-5. PubMed ID: 15804182
[TBL] [Abstract][Full Text] [Related]
17. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.
Dutta AS; Gormley JJ; Coath M; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Ferguson R; Halterman T; Jamieson A; Moors JA; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Aug; 6(8):398-412. PubMed ID: 10969869
[TBL] [Abstract][Full Text] [Related]
18. Effect of mutagenesis of GPIIb amino acid 273 on the expression and conformation of the platelet integrin GPIIb-IIIa.
Kahn MJ; Kieber-Emmons T; Vilaire G; Murali R; Poncz M; Bennett JS
Biochemistry; 1996 Nov; 35(45):14304-11. PubMed ID: 8916916
[TBL] [Abstract][Full Text] [Related]
19. Nanosized aspirin-Arg-Gly-Asp-Val: delivery of aspirin to thrombus by the target carrier Arg-Gly-Asp-Val tetrapeptide.
Jin S; Wang Y; Zhu H; Wang Y; Zhao S; Zhao M; Liu J; Wu J; Gao W; Peng S
ACS Nano; 2013 Sep; 7(9):7664-73. PubMed ID: 23931063
[TBL] [Abstract][Full Text] [Related]
20. Correlation of molecular shape with GPIIb-IIIa receptor antagonist activity in RGD peptides.
Tung JS; Jakubowski JA; Heath WF; Utterback BG; Herron DK
Receptor; 1993; 3(4):343-56. PubMed ID: 8142908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
